Dr. Inderpal Randhawa is a highly respected specialist in internal medicine, pediatrics, and immunology, with over two decades of experience. He is particularly dedicated to pulmonary and allergy medicine, and his commitment to these fields is evident in his leadership roles. He serves as the Medical Director of the Children’s Pulmonary Institute and the Program Director of the Pediatric Pulmonology Fellowship at UCI and Miller Children’s & Women’s Hospital. Additionally, Dr. Randhawa is the founder and Chief Medical Officer of the Translational Pulmonary & Immunology Research Center (TPIRC), where he focuses on treating rare, or “orphan,” diseases.
Dr. Randhawa’s extensive medical education and training have equipped him with a broad range of expertise. He earned his medical degree from Northwestern University Medical School and completed his training at several top institutions. His post-graduate work includes time at Loma Linda University Medical Center, UCLA School of Medicine, and a specialized Pediatric & Adult Pulmonology Fellowship at UC Irvine. This comprehensive background allows him to provide cutting-edge care to patients with complex pulmonary and immunological conditions.
(562) 933-8749
2801 Atlantic Ave, Long Beach, CA 90806
Stanford University: Graduated with a degree in Human Biology.
University of California, Davis, School of Medicine: Earned his Doctor of Medicine (MD) degree.
Stanford University Medical Center: Completed his residency in Pediatrics.
Stanford University School of Medicine and Lucile Packard Children’s Hospital: Completed a fellowship in Pediatric Nephrology and was awarded a research grant from the National Institutes of Health.
Specialization: Specializes in pediatric nephrology and hypertension, and is a noted expert in his field.
Dr. Inderpal Singh Randhawa represents the future of pediatric medicine, combining cutting-edge technology with deep compassion to help children with some of the most challenging respiratory and allergic conditions. What makes him truly extraordinary is his rare collection of five board certifications spanning pediatrics, internal medicine, allergy and immunology, and pulmonology, giving him an incredibly comprehensive understanding of how different systems in the body work together. As the founder of both the Translational Pulmonary & Immunology Research Center and the Food Allergy Institute, Dr. Randhawa has revolutionized how we approach life-threatening food allergies and rare respiratory diseases. He’s pioneered an innovative approach that uses advanced data analytics and machine learning to create highly personalized treatment plans, achieving success rates that seemed impossible just a few years ago.
What sets Dr. Randhawa apart is his ability to take complex medical research and translate it directly into better outcomes for the families he serves. Parents dealing with a child’s severe food allergies or rare lung condition often feel overwhelmed and scared, but Dr. Randhawa brings both hope and results. His multi-system approach doesn’t just treat symptoms, it addresses the whole child, using sophisticated data analysis to understand exactly what’s happening in each individual case. As a prolific researcher and principal investigator on numerous clinical trials, he’s constantly pushing the boundaries of what’s possible in pediatric care. Yet despite his impressive credentials and groundbreaking work, families consistently describe him as genuinely caring and accessible, someone who takes the time to explain complex treatments in ways that make sense and help them feel confident in their child’s care.
Copyright @2025